-
2
-
-
84942517244
-
Nivolumab in combination with ipilimumab for the treatment of melanoma
-
Somasundaram, R. & Herlyn, M. Nivolumab in combination with ipilimumab for the treatment of melanoma. Expert Rev. Anticancer Ther. 15, 1135-1141 (2015).
-
(2015)
Expert Rev. Anticancer Ther.
, vol.15
, pp. 1135-1141
-
-
Somasundaram, R.1
Herlyn, M.2
-
3
-
-
84864285794
-
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
-
Straussman, R. et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature. 487, 500-504 (2012).
-
(2012)
Nature.
, vol.487
, pp. 500-504
-
-
Straussman, R.1
-
4
-
-
78650008177
-
Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K
-
Villanueva, J. et al. Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K. Cancer Cell 18, 683-695 (2010).
-
(2010)
Cancer Cell
, vol.18
, pp. 683-695
-
-
Villanueva, J.1
-
5
-
-
84898738821
-
BRAF inhibitor resistance mechanisms in metastatic melanoma: Spectrum and clinical impact
-
Rizos, H. et al. BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact. Clin. Cancer Res. 20, 1965-1977 (2014).
-
(2014)
Clin. Cancer Res.
, vol.20
, pp. 1965-1977
-
-
Rizos, H.1
-
6
-
-
82955172970
-
Fibroblasts contribute to melanoma tumor growth and drug resistance
-
Flach, E. H., Rebecca, V. W., Herlyn, M., Smalley, K. S. & Anderson, A. R. Fibroblasts contribute to melanoma tumor growth and drug resistance. Mol. Pharm. 8, 2039-2049 (2011).
-
(2011)
Mol. Pharm.
, vol.8
, pp. 2039-2049
-
-
Flach, E.H.1
Rebecca, V.W.2
Herlyn, M.3
Smalley, K.S.4
Anderson, A.R.5
-
7
-
-
84858590826
-
Accessories to the crime: Functions of cells recruited to the tumor microenvironment
-
Hanahan, D. & Coussens, L. M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21, 309-322 (2012).
-
(2012)
Cancer Cell
, vol.21
, pp. 309-322
-
-
Hanahan, D.1
Coussens, L.M.2
-
8
-
-
80053401068
-
Breast cancer stem cells, cytokine networks, and the tumor microenvironment
-
Korkaya, H., Liu, S. & Wicha, M. S. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J. Clin. Invest. 121, 3804-3809 (2011).
-
(2011)
J. Clin. Invest.
, vol.121
, pp. 3804-3809
-
-
Korkaya, H.1
Liu, S.2
Wicha, M.S.3
-
9
-
-
84857746620
-
Immunotype and immunohistologic characteristics of tumorinfiltrating immune cells are associated with clinical outcome in metastatic melanoma
-
Erdag, G. et al. Immunotype and immunohistologic characteristics of tumorinfiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Res. 72, 1070-1080 (2012).
-
(2012)
Cancer Res.
, vol.72
, pp. 1070-1080
-
-
Erdag, G.1
-
10
-
-
84862001719
-
A seven-marker signature and clinical outcome in malignant melanoma: A large-scale tissue-microarray study with two independent patient cohorts
-
Meyer, S. et al. A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS ONE 7, e38222 (2012).
-
(2012)
PLoS ONE
, vol.7
, pp. e38222
-
-
Meyer, S.1
-
11
-
-
84971505166
-
Tumor associated B cells in cutaneous primary melanoma and improved clinical outcome
-
54, 157-164
-
Garg, K. et al. Tumor associated B cells in cutaneous primary melanoma and improved clinical outcome. Hum. Pathol. 54, 157-164 (2016). 54, 157-164
-
(2016)
Hum. Pathol.
, vol.54
, pp. 157-164
-
-
Garg, K.1
-
12
-
-
84911166897
-
A significant percentage of CD20-positive TILs correlates with poor prognosis in patients with primary cutaneous malignant melanoma
-
Martinez-Rodriguez, M., Thompson, A. K. & Monteagudo, C. A significant percentage of CD20-positive TILs correlates with poor prognosis in patients with primary cutaneous malignant melanoma. Histopathology 65, 726-728 (2014).
-
(2014)
Histopathology
, vol.65
, pp. 726-728
-
-
Martinez-Rodriguez, M.1
Thompson, A.K.2
Monteagudo, C.3
-
13
-
-
84878448880
-
B cells promote tumor progression via STAT3 regulatedangiogenesis
-
Yang, C. et al. B cells promote tumor progression via STAT3 regulatedangiogenesis. PLoS ONE 8, e64159 (2013).
-
(2013)
PLoS ONE
, vol.8
, pp. e64159
-
-
Yang, C.1
-
14
-
-
80051484018
-
B lymphocytes promote lymphogenous metastasis of lymphoma and melanoma
-
Ruddell, A., Harrell, M. I., Furuya, M., Kirschbaum, S. B. & Iritani, B. M. B lymphocytes promote lymphogenous metastasis of lymphoma and melanoma. Neoplasia 13, 748-757 (2011).
-
(2011)
Neoplasia
, vol.13
, pp. 748-757
-
-
Ruddell, A.1
Harrell, M.I.2
Furuya, M.3
Kirschbaum, S.B.4
Iritani, B.M.5
-
15
-
-
54249161032
-
A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: Evidence from mice and humans
-
Staquicini, F. I. et al. A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans. Cancer Res. 68, 8419-8428 (2008).
-
(2008)
Cancer Res.
, vol.68
, pp. 8419-8428
-
-
Staquicini, F.I.1
-
16
-
-
19344365408
-
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
-
de Visser, K. E., Korets, L. V. & Coussens, L. M. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7, 411-423 (2005).
-
(2005)
Cancer Cell
, vol.7
, pp. 411-423
-
-
De Visser, K.E.1
Korets, L.V.2
Coussens, L.M.3
-
17
-
-
84902465821
-
B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas
-
Affara, N. I. et al. B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas. Cancer Cell 25, 809-821 (2014).
-
(2014)
Cancer Cell
, vol.25
, pp. 809-821
-
-
Affara, N.I.1
-
18
-
-
84960124795
-
Bruton's tyrosine kinase (BTK)-dependent immune cell crosstalk drives pancreas cancer
-
Gunderson, A. J. et al. Bruton's tyrosine kinase (BTK)-dependent immune cell crosstalk drives pancreas cancer. Cancer Discov. 6, 270-285 (2016).
-
(2016)
Cancer Discov.
, vol.6
, pp. 270-285
-
-
Gunderson, A.J.1
-
19
-
-
84960123964
-
Hif1alpha deletion reveals pro-neoplastic function of B cells in pancreatic neoplasia
-
Lee, K. E. et al. Hif1alpha deletion reveals pro-neoplastic function of B cells in pancreatic neoplasia. Cancer Discov. 6, 256-269 (2016).
-
(2016)
Cancer Discov.
, vol.6
, pp. 256-269
-
-
Lee, K.E.1
-
20
-
-
77949379050
-
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
-
Ammirante, M., Luo, J. L., Grivennikov, S., Nedospasov, S. & Karin, M. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature. 464, 302-305 (2010).
-
(2010)
Nature
, vol.464
, pp. 302-305
-
-
Ammirante, M.1
Luo, J.L.2
Grivennikov, S.3
Nedospasov, S.4
Karin, M.5
-
21
-
-
0035477424
-
Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways
-
Satyamoorthy, K., Li, G., Vaidya, B., Patel, D. & Herlyn, M. Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways. Cancer Res. 61, 7318-7324 (2001).
-
(2001)
Cancer Res.
, vol.61
, pp. 7318-7324
-
-
Satyamoorthy, K.1
Li, G.2
Vaidya, B.3
Patel, D.4
Herlyn, M.5
-
22
-
-
84884368877
-
Influence of tumour micro-environment heterogeneity on therapeutic response
-
Junttila, M. R. & de Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 501, 346-354 (2013).
-
(2013)
Nature.
, vol.501
, pp. 346-354
-
-
Junttila, M.R.1
De Sauvage, F.J.2
-
23
-
-
27144557960
-
A tumorigenic subpopulation with stem cell properties in melanomas
-
Fang, D. et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 65, 9328-9337 (2005).
-
(2005)
Cancer Res
, vol.65
, pp. 9328-9337
-
-
Fang, D.1
-
24
-
-
84948744587
-
Heterogeneity in melanoma
-
Shannan, B., Perego, M., Somasundaram, R. & Herlyn, M. Heterogeneity in melanoma. Cancer Treat. Res. 167, 1-15 (2016).
-
(2016)
Cancer Treat. Res.
, vol.167
, pp. 1-15
-
-
Shannan, B.1
Perego, M.2
Somasundaram, R.3
Herlyn, M.4
-
25
-
-
57849117384
-
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1. 1)
-
Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1. 1). Eur. J. Cancer 45, 228-247 (2009).
-
(2009)
Eur. J. Cancer
, vol.45
, pp. 228-247
-
-
Eisenhauer, E.A.1
-
26
-
-
73149092567
-
Guidelines for the evaluation of immune therapy activity in solid tumors: Immune-related response criteria
-
Wolchok, J. D. et al. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin. Cancer Res. 15, 7412-7420 (2009).
-
(2009)
Clin. Cancer Res.
, vol.15
, pp. 7412-7420
-
-
Wolchok, J.D.1
-
27
-
-
84873668054
-
Tumor-infiltrating B cells: The ignored players in tumor immunology
-
Linnebacher, M. & Maletzki, C. Tumor-infiltrating B cells: the ignored players in tumor immunology. Oncoimmunology 1, 1186-1188 (2012).
-
(2012)
Oncoimmunology
, vol.1
, pp. 1186-1188
-
-
Linnebacher, M.1
Maletzki, C.2
-
28
-
-
84862557227
-
CD20+ tumor-infiltrating lymphocytes have an atypical CD27-memory phenotype and together with CD8+T cells promote favorable prognosis in ovarian cancer
-
Nielsen, J. S. et al. CD20+ tumor-infiltrating lymphocytes have an atypical CD27-memory phenotype and together with CD8+T cells promote favorable prognosis in ovarian cancer. Clin. Cancer Res. 18, 3281-3292 (2012).
-
(2012)
Clin. Cancer Res.
, vol.18
, pp. 3281-3292
-
-
Nielsen, J.S.1
-
29
-
-
84872229121
-
Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer
-
Yang, C. et al. Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer. PLoS ONE 8, e54029 (2013).
-
(2013)
PLoS ONE
, vol.8
, pp. e54029
-
-
Yang, C.1
-
30
-
-
82355169702
-
Prognostic impact of B-cell density in cutaneous melanoma
-
Ladanyi, A. et al. Prognostic impact of B-cell density in cutaneous melanoma. Cancer Immunol. Immunother. 60, 1729-1738 (2011).
-
(2011)
Cancer Immunol. Immunother.
, vol.60
, pp. 1729-1738
-
-
Ladanyi, A.1
-
31
-
-
78149488860
-
CD20+B cells: The other tumor-infiltrating lymphocytes
-
Nelson, B. H. CD20+B cells: the other tumor-infiltrating lymphocytes. J. Immunol. 185, 4977-4982 (2010).
-
(2010)
J. Immunol.
, vol.185
, pp. 4977-4982
-
-
Nelson, B.H.1
-
32
-
-
84893203731
-
Tumor infiltrating B-cells are increased in prostate cancer tissue
-
Woo, J. R. et al. Tumor infiltrating B-cells are increased in prostate cancer tissue. J. Transl. Med. 12, 30 (2014).
-
(2014)
J. Transl. Med.
, vol.12
, pp. 30
-
-
Woo, J.R.1
-
33
-
-
84960076087
-
IL-35 producing B cells promote the development of pancreatic neoplasia
-
6, 247-255
-
Pylayeva-Gupta, Y. et al. IL-35 producing B cells promote the development of pancreatic neoplasia. Cancer Discov. 6, 247-255 (2015). 6, 247-255
-
(2015)
Cancer Discov.
, vol.6
, pp. 247-255
-
-
Pylayeva-Gupta, Y.1
-
34
-
-
84929085260
-
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
-
Shalapour, S. et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature 521, 94-98 (2015).
-
(2015)
Nature
, vol.521
, pp. 94-98
-
-
Shalapour, S.1
-
35
-
-
50349097319
-
Human B cell subsets
-
Jackson, S. M., Wilson, P. C., James, J. A. & Capra, J. D. Human B cell subsets. Adv. Immunol. 98, 151-224 (2008).
-
(2008)
Adv. Immunol.
, vol.98
, pp. 151-224
-
-
Jackson, S.M.1
Wilson, P.C.2
James, J.A.3
Capra, J.D.4
-
36
-
-
61649100307
-
The FGF family: Biology, pathophysiology and therapy
-
Beenken, A. & Mohammadi, M. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug. Discov. 8, 235-253 (2009).
-
(2009)
Nat. Rev. Drug. Discov.
, vol.8
, pp. 235-253
-
-
Beenken, A.1
Mohammadi, M.2
-
37
-
-
84928174677
-
Therapy-induced tumour secretomes promote resistance and tumour progression
-
Obenauf, A. C. et al. Therapy-induced tumour secretomes promote resistance and tumour progression. Nature 520, 368-372 (2015).
-
(2015)
Nature
, vol.520
, pp. 368-372
-
-
Obenauf, A.C.1
-
38
-
-
79952302092
-
Eradication of melanomas by targeted elimination of a minor subset of tumor cells
-
Schmidt, P. et al. Eradication of melanomas by targeted elimination of a minor subset of tumor cells. Proc. Natl Acad. Sci. USA 108, 2474-2479 (2011).
-
(2011)
Proc. Natl Acad. Sci. USA
, vol.108
, pp. 2474-2479
-
-
Schmidt, P.1
-
39
-
-
84864994126
-
Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma
-
Yadav, V. et al. Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma. J. Biol. Chem. 287, 28087-28098 (2012).
-
(2012)
J. Biol. Chem.
, vol.287
, pp. 28087-28098
-
-
Yadav, V.1
-
40
-
-
80052866912
-
Fibroblast growth factor receptors as therapeutic targets in human melanoma: Synergism with BRAF inhibition
-
Metzner, T. et al. Fibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition. J. Invest. Dermatol. 131, 2087-2095 (2011).
-
(2011)
J. Invest. Dermatol.
, vol.131
, pp. 2087-2095
-
-
Metzner, T.1
-
41
-
-
74949143594
-
Final version of 2009 AJCC melanoma staging and classification
-
Balch, C. M. et al. Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol. 27, 6199-6206 (2009).
-
(2009)
J. Clin. Oncol.
, vol.27
, pp. 6199-6206
-
-
Balch, C.M.1
-
42
-
-
0021341671
-
Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C
-
Russell, W. E., Van Wyk, J. J. & Pledger, W. J. Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C. Proc. Natl Acad. Sci. USA 81, 2389-2392 (1984).
-
(1984)
Proc. Natl Acad. Sci. USA
, vol.81
, pp. 2389-2392
-
-
Russell, W.E.1
Van Wyk, J.J.2
Pledger, W.J.3
-
43
-
-
35848956117
-
Upregulation of IGF-2 and IGF-1 receptor expression in oral cancer cell lines
-
Brady, G., Crean, S. J., Naik, P. & Kapas, S. Upregulation of IGF-2 and IGF-1 receptor expression in oral cancer cell lines. Int. J. Oncol. 31, 875-881 (2007).
-
(2007)
Int. J. Oncol.
, vol.31
, pp. 875-881
-
-
Brady, G.1
Crean, S.J.2
Naik, P.3
Kapas, S.4
-
44
-
-
1642422358
-
The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation
-
Cheung, C. W., Vesey, D. A., Nicol, D. L. & Johnson, D. W. The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. Kidney. Int. 65, 1272-1279 (2004).
-
(2004)
Kidney. Int.
, vol.65
, pp. 1272-1279
-
-
Cheung, C.W.1
Vesey, D.A.2
Nicol, D.L.3
Johnson, D.W.4
-
45
-
-
0034650596
-
CD4(+), HLA class I-restricted, cytolytic Tlymphocyte clone against primary malignant melanoma cells
-
Somasundaram, R. et al. CD4(+), HLA class I-restricted, cytolytic Tlymphocyte clone against primary malignant melanoma cells. Int. J. Cancer 85, 253-259 (2000).
-
(2000)
Int. J. Cancer
, vol.85
, pp. 253-259
-
-
Somasundaram, R.1
-
46
-
-
0141613181
-
An efficient method for the rapid establishment of Epstein-Barr virus immortalization of human B lymphocytes
-
Oh, H. M. et al. An efficient method for the rapid establishment of Epstein-Barr virus immortalization of human B lymphocytes. Cell Prolif. 36, 191-197 (2003).
-
(2003)
Cell Prolif.
, vol.36
, pp. 191-197
-
-
Oh, H.M.1
-
47
-
-
84890774497
-
Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target
-
Rasanen, K. et al. Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target. Mol. Cell Proteomics 12, 3778-3792 (2013).
-
(2013)
Mol. Cell Proteomics
, vol.12
, pp. 3778-3792
-
-
Rasanen, K.1
-
48
-
-
77957069138
-
Detection of individual endogenous RNA transcripts in situ using multiple singly labeled probes
-
Raj, A. & Tyagi, S. Detection of individual endogenous RNA transcripts in situ using multiple singly labeled probes. Methods Enzymol. 472, 365-386 (2010).
-
(2010)
Methods Enzymol.
, vol.472
, pp. 365-386
-
-
Raj, A.1
Tyagi, S.2
-
49
-
-
46249088370
-
Lumi: A pipeline for processing Illumina microarray
-
Du, P., Kibbe, W. A. & Lin, S. M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547-1548 (2008).
-
(2008)
Bioinformatics
, vol.24
, pp. 1547-1548
-
-
Du, P.1
Kibbe, W.A.2
Lin, S.M.3
-
50
-
-
84988531155
-
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
-
Zhang, G. et al. Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors. J. Clin. Invest. 126, 1-41 (2016).
-
(2016)
J. Clin. Invest.
, vol.126
, pp. 1-41
-
-
Zhang, G.1
-
51
-
-
84926332167
-
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma
-
Kwong, L. N. et al. Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma. J. Clin. Invest. 125, 1459-1470 (2015).
-
(2015)
J. Clin. Invest.
, vol.125
, pp. 1459-1470
-
-
Kwong, L.N.1
-
52
-
-
84897397058
-
FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features
-
Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923-930 (2014).
-
(2014)
Bioinformatics
, vol.30
, pp. 923-930
-
-
Liao, Y.1
Smyth, G.K.2
Shi, W.3
-
53
-
-
33645531525
-
Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patients
-
Somasundaram, R. et al. Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patients. Cancer Res. 66, 3287-3293 (2006).
-
(2006)
Cancer Res.
, vol.66
, pp. 3287-3293
-
-
Somasundaram, R.1
-
54
-
-
84877001084
-
Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence
-
Aird, K. M. et al. Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep. 3, 1252-1265 (2013).
-
(2013)
Cell Rep.
, vol.3
, pp. 1252-1265
-
-
Aird, K.M.1
-
55
-
-
84860531228
-
Targeting CD20 in melanoma patients at high risk of disease recurrence
-
Pinc, A. et al. Targeting CD20 in melanoma patients at high risk of disease recurrence. Mol. Ther. 20, 1056-1062 (2012).
-
(2012)
Mol. Ther.
, vol.20
, pp. 1056-1062
-
-
Pinc, A.1
-
56
-
-
0030853288
-
Melanoma cell lines from different stages of progression and their biological and molecular analyses
-
Satyamoorthy, K. et al. Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res. 7, S35-42 (1997).
-
(1997)
Melanoma Res.
, vol.7
, pp. S35-42
-
-
Satyamoorthy, K.1
-
57
-
-
84855441276
-
Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma
-
Xu, X. et al. Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma. Clin. Cancer Res. 18, 229-237 (2011).
-
(2011)
Clin. Cancer Res.
, vol.18
, pp. 229-237
-
-
Xu, X.1
-
58
-
-
84864764964
-
Differentiation-induced skin cancer suppression by FOS p53, and TACE/ADAM17
-
Guinea-Viniegra, J. et al. Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17. J. Clin. Invest. 122, 2898-2910 (2012).
-
(2012)
J. Clin. Invest.
, vol.122
, pp. 2898-2910
-
-
Guinea-Viniegra, J.1
-
59
-
-
84869213410
-
Quantitative immunofluorescence reveals the signature of active B-cell receptor signaling in diffuse large B-cell lymphoma
-
Bogusz, A. M. et al. Quantitative immunofluorescence reveals the signature of active B-cell receptor signaling in diffuse large B-cell lymphoma. Clin. Cancer Res. 18, 6122-6135 (2012).
-
(2012)
Clin. Cancer Res.
, vol.18
, pp. 6122-6135
-
-
Bogusz, A.M.1
|